Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Clinical trial NCT06659445 · RECRUITING

Trial details

NCT number: NCT06659445
Sponsor: ONL Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Geographic Atrophy (GA)Age - Related Macular Degeneration (AMD)

Start date: 2025-10-28
Primary completion: 2028-11-01
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.